Literature DB >> 27115026

In vitro antimycobacterial and cytotoxic data on medicinal plants used to treat tuberculosis.

Joseph M Nguta1, Regina Appiah-Opong2, Alexander K Nyarko2, Dorothy Yeboah-Manu3, Phyllis G A Addo4, Isaac D Otchere3, Abena Kissi-Twum2.   

Abstract

This article contains data on in vitro antimycobacterial activity and cytotoxicity of hydroethanolic crude extracts from five selected medicinal plant species traditionally used to treat tuberculosis in Ghanaian ethnomedicine, see "Medicinal plants used to treat TB in Ghana" [1]. The interpretation and discussion of these data and further extensive insights into drug discovery against tuberculosis from natural products of plant biodiversity can be found in "Antimycobacterial and cytotoxic activity of selected medicinal plant extracts" [2].

Entities:  

Keywords:  Crude extracts; MABA assay; MTS assay; Medicinal plants; Tuberculosis; in vitro antimycobacterial; in vitro cytotoxicity

Year:  2016        PMID: 27115026      PMCID: PMC4833128          DOI: 10.1016/j.dib.2016.03.088

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specification table

Value of the data

This data provides a comprehensive in vitro antimycobacterial activity of hydroethanolic total extracts from five selected medicinal plants which can serve as a benchmark for other researchers. This data set includes in vitro cytotoxicity values from five selected ethnobotanicals and reference anti-TB drugs which can be used as a basis for further research. This data may provide insights for future drug development against tuberculosis. The data set can be used to guide further isolation of anti-TB compounds. This data set can be used for external validation of data acquired from similar experiments.

Data

Data on comparative antimycobacterial activity of total hydroethanolic extracts derived from five medicinal plant species is presented (Table 1). Data on in vitro cytotoxic activity of tested plant species and positive control drugs, isoniazid, rifampicin and ethambutol against MRC-5, human fetal lung fibroblast cell line (ATCC® CCL-171™) is shared in Table 2.
Table 1

Comparative minimum inhibitory concentration (MIC in mg/mL) values of selected plant species against pathogenic and non-pathogenic mycobacterial strains.

Solanum torvumChenopodium ambrosioidesDissotis rotundifoliaZingiber officinaleAloe vera var. barbadensisIsoniazidRifampicinEthambutol
M. tb H37Rv(ATCC® 27294™)1.25>1051050.000030.000030.002
M. smegmatis(ATCC® 19420™)2.5101010100.0020.0020.00025
M. tb; Strain H37Ra(ATCC® 25177™)0.15635>102.52.50.000080.00050.0005
Table 2

Cytotoxic activity of selected medicinal plant species against human fetal lung fibroblast cell line, MRC-5 (ATCC® CCL-171™).

Plant speciesConcentration (mg/mL)Absorbance 1Absorbance 2Absorbance 3MeanCorrected meanStandard deviation% cell viabilityBlankNegative control
Solanum torvum00.25090.25090.25090.25090.15970.000100.000.08650.2578
0.6250.44180.44960.44340.44490.20760.004130.010.09690.2687
1.250.41680.39840.39600.40370.05310.011033.270.09500.2651
2.50.60050.60300.58250.59530.15270.011095.640.08140.2674
50.99410.94380.93560.95780.35670.0320223.380.09850.2696
101.43391.53941.49531.48950.18690.053117.050.09800.2625
Chenopodium ambrosioides00.25090.25090.25090.25090.15970.000100.000.08950.1989
0.6250.26140.25960.17890.23330.10110.047063.310.09570.2469
1.250.26780.29200.21170.25720.12090.041075.680.15660.2556
2.50.29470.30780.19210.26490.13240.063082.880.09120.2578
50.29860.32640.20050.27520.12320.06677.120.10030.2372
100.18010.21190.13840.1768−0.01620.0370−10.140.0910.2253
Dissotis rotundifolia00.25090.25090.25090.25090.15970.000100.000.0870.2023
0.6250.29940.33320.34280.32510.07620.023047.740.10630.2603
1.250.31270.32520.35030.32940.01500.0199.390.10.2690
2.50.29600.33420.34210.3241−0.04050.025−25.360.090.2728
50.46180.48400.50690.4842−0.06030.023−37.740.10420.2676
100.79120.70250.87400.7892−0.22130.0860−138.50.08760.2699
Zingiber officinale00.25090.25090.25090.25090.15970.000100.000.09790.0912
0.6250.26920.27960.26490.27120.13220.00882.800.08920.1390
1.250.31640.33870.26550.30690.17320.038108.430.08800.1337
2.50.16810.15770.18580.17050.02160.01413.550.07880.1489
50.18740.22490.27190.22810.03110.04219.450.08790.1970
100.38330.47110.40200.41880.15900.046099.560.09420.2598
Aloe vera var. barbadensis00.25090.25090.25090.25090.15970.000100.000.08880.0912
0.6250.29020.28860.27700.28530.12690.00779.440.08540.1584
1.250.28630.27730.26250.27540.13890.012086.950.09160.1365
2.50.30270.28910.28060.29080.12580.011078.770.08120.1650
50.19070.18520.19380.1899−0.01480.004−9.270.08450.2047
100.19640.20240.20190.2002−0.03190.003−19.950.08930.2321
Isoniazid00.35470.35470.35470.35470.14270.000100.000.21360.2120
0.6250.45010.35520.32960.37830.15690.0630109.950.21170.2214
1.250.34410.32820.35650.34290.12140.014085.0970.20640.2215
2.50.38150.38820.34760.37240.15330.0220107.450.20970.2191
50.33270.49340.34310.38970.17480.0900122.510.22790.2149
100.46520.34550.36210.39090.17010.0650119.220.23030.2208
Rifampicin00.35470.35470.35470.35470.14270.000100.000.21390.2120
0.6250.41200.34820.33520.36510.14680.041102.8970.20890.2183
1.250.34500.41930.35110.37180.09360.04165.5920.20980.2782
2.50.35970.38250.35290.36500.10330.016072.4130.20850.2617
50.35140.36100.37700.36310.12680.01388.8810.20700.2363
100.38590.38300.45860.40920.16060.043112.520.23190.2486
Ethambutol00.35470.35470.35470.35470.14270.000100.000.20250.2120
0.6250.39090.37560.35500.37380.15570.0180109.1330.21280.2181
1.250.33800.35490.34420.34570.12310.00986.2650.181120.2226
2.50.34980.32870.33090.33650.12490.012087.5030.21320.2116
50.34470.36960.32540.34660.13540.022094.8610.17390.2112
100.35110.33960.33040.34040.10370.010072.6470.20960.2367

Experimental design, materials and methods

Antibiotics and chemicals

Antimycobacterial reference standards [(ethambutol hydrochloride, European pharmacopoeia (EP) reference standard (EMB); Isoniazid >99%, (INH) and rifampicin 95% (RIF)] were all obtained from Sigma-Aldrich (St. Louis, MO) and stock solutions at 1000 μg/mL filter sterilized and stored at −20 °C until use. Middlebrook 7H9 broth supplemented with 0.05% (vol/vol) Tween 80 (Sigma); 10% OADC (oleic acid, albumin, dextrose, and catalase); Becton-Dickinson; 0.1% casitone and 0.5% glycerol was used to prepare working solutions at the following concentrations: RIF and EMB, 16 μg/mL; INH, 1.6 μg/mL and crude extracts, 10,000 μg/mL. A mixture of 10% Tween 80 and 10× Alamar blue dye (Alamar Biosciences/Accumed, Westlake, OH), at the ratio of 1:1 was prepared and stored at 4 °C for up to 1 week after sterilization by filtration.

Collection and preparation of plant materials

The rhizomes of Zingiber officinale and the leaves of Chenopodium ambrosioides, Dissotis rotundifolia, Aloe vera var. barbadensis and Solanum torvum were collected from the eastern region of Ghana, identified and prepared for bioassays as earlier described [1], [2].

Antimycobacterial assay

Mycobacterial strains and growth conditions

Non-pathogenic fast growing mycobacterial strain, Mycobacterium smegmatis (ATCC®19420™), non-pathogenic slow growing strain, Mycobacterium tuberculosis; Strain H37Ra (ATCC® 25177™) and slow growing pathogenic laboratory strain, Mycobacterium tuberculosis subsp.tuberculosis (ATCC® 27294™) were obtained from American Type Culture Collection (Manassas, VA 20108, USA). The mycobacterial strains were maintained on Lowenstein–Jensen slopes and cultured on enriched media comprising of Middlebrook 7H9 broth (Difco, Detroit, MI) supplemented with 0.05% (vol/vol) Tween 80 (Sigma); 10% (vol/vol) OADC (oleic acid, albumin, dextrose, catalase; Difco), 1.0 g of casitone (Difco) per liter and 0.2% (vol/vol) glycerol (Sigma Chemical Co., Saint Louis, MO). The enriched culture medium was referred to as 7H9GC-Tween. Cultures were incubated at an aerobic atmosphere at 37 °C.

Microplate alamar blue assay (MABA)

Mycobacterial strains were maintained on Lowenstein Jensen slopes, while the test inoculum was prepared in 7H9GC-tween broth, adjusted to a no. 1 McFarland tube standard, to give approximately 3.0×108 cells and further diluted at the ration of 1:10 in the enriched broth (7H9GC-Tween) for anti-TB bioassays [2], [3]. The assay was conducted as earlier described by Nguta et al. [2] and Palomino et al. [3]. Briefly, 100 μL of the enriched broth was dispensed in each well of a sterile flat-bottom 96-well plate, followed by serial two-fold dilutions of the crude extracts. The positive control drugs were prepared directly in the microtiter plate. One hundred microliters (100 μL) of the prepared inoculum was added to each well. A sterile control comprising of the medium only and a growth control consisting of cells and growth medium were also included for each experiment. Evaporation during the incubation period was minimized by addition of sterile water to all perimeter wells of the 96-well microtiter plate. The covered microtiter plates were sealed in plastic bags and incubated at 37 °C under a normal atmosphere. After 7 days of incubation for M. tuberculosis H37Ra and M. tuberculosis subsp. tuberculosis, and 48 h of incubation for M. smegmatis, 30 μL of a mixture of 10% tween 80 and alamar blue solution in a ratio of 1:1 was added to each well, and the plate incubated overnight. A color change from blue to pink indicated mycobacterial growth, and the minimum inhibitory concentration (MIC) was taken as the highest dilution of the crude extract or positive control drug that prevented color change from blue to pink. The drug and crude extract concentration ranges used for the experiments were as follows: for positive controls, INH, 0.025–1.6 μg/mL, EMB and RIF, 0.25–16 μg/mL and for crude extracts, 10,000–19.5 μg/mL. All the tests were run in triplicate in a biosafety level three (BSL-3) laboratory.

in vitro cytotoxic evaluation

Chemicals and reagents

Chemicals and reagents for cytotoxic investigations were procured from Promega (USA), Sigma (USA) and Gibco (USA).

MRC-5 cell lines and culture conditions

Human fetal lung fibroblast cell line, MRC-5 (ATCC® CCL-171™) was procured from the American Type Culture Collection (ATCC) (Manassas, VA 20108, USA). Cultures for cytotoxic evaluation were maintained in a phenol red free Dulbecco׳s modified essential medium/Ham׳s 12 nutrient mixture (DMEM/F12), (Gibco), supplemented with 1% (vol/vol) antibiotic [(2 mM L-glutamine, 100 U/mL Penicillin and 100 μg/mL Streptomycin; (Gibco)] and 5% [(vol/vol) fetal calf serum (JS Bioscience, Australia)]. MRC-5 fibroblast cells were incubated at 37 °C in a humidified 5% carbon dioxide incubator. The culture medium was removed from the flask and the cells were rinsed three times with sterile Hank׳s Balanced Salt Solution (HBSS), (Gibco), once the cells reached confluence. Trypsin/EDTA (Gibco, USA), was used to enzymatically remove the confluent layers, followed by suspension in culture medium. A light microscope (Leitz Wetzlar, Germany) was used to determine cell numbers after vital staining with trypan blue (0.4% (wt/vol); Sigma, USA).

Preparation of test extracts

Total (crude) extracts were suspended in enriched phenol free Dulbecco׳s modified essential medium/Ham׳s 12 nutrient mixture (DMEM/F12), (Gibco) at the concentration of 10 000 μg/mL and dispersed by ultrasonic vibration for 15 min. Crude extracts were stirred on a vortex for one minute before every use to ensure uniform suspension.

MTS assay

in vitro cytotoxicity assay was performed using the Promega CellTiter 96 AQueous Non-Radioactive Cell Proliferation (MTS) assay as earlier described [2], [4]. The procedure for cytotoxic evaluation was adopted from manufacturer׳s instructions and previously published papers ([5], [6]). Total extracts were suspended in enriched Dulbecco׳s modified essential medium/Ham׳s/12 nutrient mixture, followed by serial dilution across 96-well microtiter plates (100 μL), and incubation at 37 °C with 5% carbon dioxide (CO2) for a period of 24 h in a humidified CO2 incubator. Four (4 h) hours prior to the end of each experiment, an MTS mixture (20 μL/well) was added to each of the test wells of the 96-well microtiter plate. The plates were then placed on a microwell plate reader (Tecan, Austria, GmbH), shaken for 10 s and the absorbance of the formazan product read at 490 nm after the completion of each exposure period. Each experiment was run in triplicate. For each experiment, two internal controls were set: (i) IC100 consisting of medium only and (ii) an IC0 consisting of cells only. Background absorbance due to the non-specific reaction between the MTS reagent and the crude extracts was deducted from exposed cell values [7].

Conflict of interest declaration

We declare no conflict of interest.
Subject areaPharmacology and Toxicology
More specific subject areaDrug discovery against tuberculosis
Type of dataTables
How data was acquiredin vitro antimycobacterial data was acquired using Microplate alamar blue assay (MABA), while cytotoxicity data was generated using MTS assay, with absorbance being read at 490 nm using Infinite M200 ProTMplate reader (Tecan, Austria, GmbH)
Data formatAnalyzed
Experimental factorsTest samples extracted with 80% ethanol by cold maceration, concentrated and lyophilized. Test crude extracts were dissolved in distilled water. Positive controls were prepared according to manufacturer׳s instructions
Experimental featuresMABA was utilized to generate MIC values while MTS assay was used to evaluate cytotoxicity.
Data source locationDepartment of Clinical Pathology, Noguchi Memorial Institute for Medical Research, University of Ghana, Ghana and Department of Public Health, Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Nairobi, Kenya
Data accessibilityData within this article
  6 in total

1.  Medicinal plants used to treat TB in Ghana.

Authors:  Joseph Mwanzia Nguta; Regina Appiah-Opong; Alexander K Nyarko; Dorothy Yeboah-Manu; Phyllis G A Addo
Journal:  Int J Mycobacteriol       Date:  2015-03-28

2.  In vitro cytotoxicity testing of airborne formaldehyde collected in serum-free culture media.

Authors:  S Bakand; A Hayes; C Winder; C Khalil; B Markovic
Journal:  Toxicol Ind Health       Date:  2005-09       Impact factor: 2.273

Review 3.  Toxicity assessment of industrial chemicals and airborne contaminants: transition from in vivo to in vitro test methods: a review.

Authors:  S Bakand; C Winder; C Khalil; A Hayes
Journal:  Inhal Toxicol       Date:  2005-12-01       Impact factor: 2.724

4.  Toxicity of Australian essential oil Backhousia citriodora (Lemon myrtle). Part 1. Antimicrobial activity and in vitro cytotoxicity.

Authors:  A J Hayes; B Markovic
Journal:  Food Chem Toxicol       Date:  2002-04       Impact factor: 6.023

5.  Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis.

Authors:  Juan-Carlos Palomino; Anandi Martin; Mirtha Camacho; Humberto Guerra; Jean Swings; Françoise Portaels
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

6.  Antimycobacterial and cytotoxic activity of selected medicinal plant extracts.

Authors:  Joseph M Nguta; Regina Appiah-Opong; Alexander K Nyarko; Dorothy Yeboah-Manu; Phyllis G A Addo; Isaac Otchere; Abena Kissi-Twum
Journal:  J Ethnopharmacol       Date:  2016-02-11       Impact factor: 4.360

  6 in total
  3 in total

1.  Eco-Friendly Synthesis of MnO2 Nanorods Using Gmelina arborea Fruit Extract and Its Anticancer Potency Against MCF-7 Breast Cancer Cell Line.

Authors:  Chandrashekar Srinivasa; Chandan Shivamallu; Shiva Prasad Kollur; S R Santosh Kumar; Sushma Pradeep; Shashanka K Prasad; Ravindra Veerapur; Mohammad Azam Ansari; Mohammad N Alomary; Saad Alghamdi; Mazen Almehmadi; Kavitha Gc; Azharuddin B Daphedar; Siddappa B Kakkalameli
Journal:  Int J Nanomedicine       Date:  2022-02-25

2.  Analysis of Cytotoxicity of Selected Asteraceae Plant Extracts in Real Time, Their Antioxidant Properties and Polyphenolic Profile.

Authors:  Patrycja Sowa; Dana Marcinčáková; Michał Miłek; Ewelina Sidor; Jaroslav Legáth; Małgorzata Dżugan
Journal:  Molecules       Date:  2020-11-25       Impact factor: 4.411

3.  Medicinal Plants Used in the Treatment of Mental and Neurological Disorders in Ghana.

Authors:  Patrick Amoateng; Emmanuel Quansah; Thomas K Karikari; Alex Asase; Dorcas Osei-Safo; Kennedy Kwami Edem Kukuia; Isaac Kingsley Amponsah; Alexander K Nyarko
Journal:  Evid Based Complement Alternat Med       Date:  2018-12-20       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.